VA Antipsychotic Diabetes Risk Studies Continue; First Report Helps Zyprexa

The Department of Veteran's Affairs plans to conduct a study on the incidence of diabetes among patients receiving combination antipsychotic therapy as a follow up to its study of patients on monotherapy